L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity.
Rii J, Sakamoto S, Mizokami A, Xu M, Fujimoto A, Saito S, Koike H, Tamura T, Arai T, Yamada Y, Goto Y, Sazuka T, Imamura Y, Suzuki K, Kanai Y, Anzai N, Ichikawa T.
Rii J, et al. Among authors: suzuki k.
Cancer Sci. 2024 Mar;115(3):937-953. doi: 10.1111/cas.16062. Epub 2024 Jan 7.
Cancer Sci. 2024.
PMID: 38186218
Free PMC article.